This November for Native American Heritage Month, the Lupus Foundation of America (LFA) celebrates Native American people and their contributions, culture, history, and traditions. We're also using ...
Fate Therapeutics, a clinical-stage biopharmaceutical company, announced promising preliminary clinical trial results for FT819, an investigational CAR T-cell therapy for people living with systemic ...
A new study of adults with systemic lupus erythematosus (SLE) found those with mental health diagnoses (depression, anxiety, and posttraumatic stress disorder (PTSD)) have much higher repeat emergency ...
A new pooled analysis of adults with systemic lupus erythematosus (SLE) found commonly used patient-reported measures varied meaningfully in sensitivity to clinical changes in SLE, disease course and ...
Novartis and Bristol Myers Squibb have paused their clinical trials studying their respective CAR-T cell therapies for lupus and other autoimmune diseases while they review safety findings. Novartis ...
New research is shedding light on the biological mechanisms that may help explain why systemic lupus erthyematosus (SLE) and other autoimmune diseases are more common in women. Two studies from the ...
The U.S. Food & Drug Administration (FDA) has granted approval for subcutaneous administration of anifrolumab (SAPHNELO) for treatment of people living with moderately to severely active ...
Interested in getting research like this straight to your inbox? Subscribe to our monthly Inside Lupus Research email for all the latest. Listen to the Latest Episode of The Expert Series Podcast A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results